ANNA MELISA LOPEZ-SANGLAY: Open Payments
NPI 1245647528 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,158 in 262 payments from 20 companies in 2025. Trend: 2023 $9,446 · 2024 $14,351 · 2025 $10,158
Food & beverage: $7,419Consulting: $2,475Education: $263
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $1,479 |
| ABBVIE INC. | 21 | $1,179 |
| GENZYME CORPORATION | 18 | $1,175 |
| UCB, Inc. | 33 | $1,125 |
| LEO Pharma Inc. | 14 | $920 |
| Arcutis Biotherapeutics, Inc. | 36 | $858 |
| Galderma Laboratories, L.P. | 24 | $679 |
| Janssen Biotech, Inc. | 13 | $465 |
| E.R. Squibb & Sons, L.L.C. | 27 | $455 |
| Regeneron Healthcare Solutions, Inc. | 9 | $391 |
Products named: Bimzelx, DUPIXENT, Zoryve, RINVOQ, ANZUPGO, TREMFYA, NEMLUVIO, Sotyktu.
Industry payments across NV — which companies pay providers there.
